Bioteque
Bioteque Corporation manufactures and sells medical device in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage… Read more
Market Cap & Net Worth: Bioteque (4107)
Bioteque (TWO:4107) has a market capitalization of $249.24 Million (NT$8.25 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #15076 globally and #540 in its home market, demonstrating a -0.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioteque's stock price NT$119.00 by its total outstanding shares 69298000 (69.30 Million).
Bioteque Market Cap History: 2015 to 2026
Bioteque's market capitalization history from 2015 to 2026. Data shows growth from $201.52 Million to $249.24 Million (3.20% CAGR).
Bioteque Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioteque's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Bioteque's market cap is 0.12 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.49x
Bioteque's market cap is 0.49 times its annual earnings
841.57x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $201.52 Million | $1.26 Billion | $315.77 Million | 0.16x | 0.64x |
| 2016 | $189.40 Million | $1.41 Billion | $358.23 Million | 0.13x | 0.53x |
| 2017 | $161.63 Million | $1.42 Billion | $303.94 Million | 0.11x | 0.53x |
| 2018 | $159.89 Million | $1.61 Billion | $405.00 Million | 0.10x | 0.39x |
| 2019 | $227.68 Million | $1.86 Billion | $464.17 Million | 0.12x | 0.49x |
| 2020 | $238.72 Million | $1.95 Billion | $488.67 Million | 0.12x | 0.49x |
| 2021 | $213.57 Million | $1.83 Billion | $431.26 Million | 0.12x | 0.50x |
| 2022 | $216.41 Million | $2.01 Billion | $493.54 Million | 0.11x | 0.44x |
| 2023 | $222.48 Million | $1.94 Billion | $452.55 Million | 0.11x | 0.49x |
| 2024 | $258.67 Million | $2.07 Billion | $528.26 Million | 0.12x | 0.49x |
Competitor Companies of 4107 by Market Capitalization
Companies near Bioteque in the global market cap rankings as of March 18, 2026.
Key companies related to Bioteque by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #99 globally with a market cap of $170.64 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #355 globally with a market cap of $61.46 Billion USD ( €59.87 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.52 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #99 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.64 Billion | $483.46 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #355 | EssilorLuxottica S. A. | PA:EL | $61.46 Billion | €203.90 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.52 Billion | $160.27 |
Bioteque Historical Marketcap From 2015 to 2026
Between 2015 and today, Bioteque's market cap moved from $201.52 Million to $ 249.24 Million, with a yearly change of 3.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$249.24 Million | -1.24% |
| 2025 | NT$252.38 Million | -2.43% |
| 2024 | NT$258.67 Million | +16.27% |
| 2023 | NT$222.48 Million | +2.80% |
| 2022 | NT$216.41 Million | +1.33% |
| 2021 | NT$213.57 Million | -10.53% |
| 2020 | NT$238.72 Million | +4.85% |
| 2019 | NT$227.68 Million | +42.40% |
| 2018 | NT$159.89 Million | -1.08% |
| 2017 | NT$161.63 Million | -14.67% |
| 2016 | NT$189.40 Million | -6.01% |
| 2015 | NT$201.52 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Bioteque was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $249.24 Million USD |
| MoneyControl | $249.24 Million USD |
| MarketWatch | $249.24 Million USD |
| marketcap.company | $249.24 Million USD |
| Reuters | $249.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.